feedback welcome

Nortriptyline-citalopram

From Psychiatrynet

(Difference between revisions)
Jump to:navigation, search
[draft revision][draft revision]
Line 6: Line 6:
* '''Day 1:''' reduce dosage of nortriptyline to 50 mg/day.
* '''Day 1:''' reduce dosage of nortriptyline to 50 mg/day.
* '''Day 3:''' reduce dosage of nortriptyline to 25 mg/day.
* '''Day 3:''' reduce dosage of nortriptyline to 25 mg/day.
 +
* '''Day 8:''' stop administration of nortriptyline.
| start =  
| start =  
-
* '''Day 1:''' simultaneously start administration of citalopram/escitalopram in a normal dosage of 20 mg/day, resp. 10 mg/day.
+
* '''Day 1:''' simultaneously start administration of citalopram in a normal dosage of 20 mg/day.
-
* '''Day 8:''' stop administration of nortriptyline and continue administration of citalopram/escitalopram.
+
| info =  
| info =  
-
* Citalopram/escitalopram are a weak inhibitor of CYP2D6, which metabolizes nortriptyline.   
+
* Citalopram is a weak inhibitor of CYP2D6, which metabolizes nortriptyline.   
}}
}}

Revision as of 22:46, 4 March 2010

Nortriptyline
Type Antidepressant
Group TCA
links
Medscape Nortriptyline
PubChem 4543
PubMed Nortriptyline
Kompas (Dutch) Nortriptyline
Wikipedia Nortriptyline
Citalopram
Type Antidepressant
Group SSRI
links
ATC-code N06AB04
Medscape Citalopram
PubChem 2771
PubMed Citalopram
Kompas (Dutch) citalopram
Wikipedia citalopram

Switch medication from nortriptyline to citalopram.

Nietinrijdenbord.png Stop nortriptyline
Eenrichtingbord.png Start citalopram
Infobord.png More information
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
Navigation
About